Combined effects of 5-azacytidine and oleuropein on miR-149-3p, miR-375, miR-574-5p expression and apoptosis in acute myeloid leukemia (AML) cell lines HL-60 and THP-1
- 17 October 2025
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-9
Abstract
Background Acute myeloid leukemia (AML) is an aggressive hematological malignancy characterized by the rapid proliferation of immature myeloid cells and poor clinical outcomes. Despite conventional treatments such as chemotherapy and hematopoietic stem cell transplantation, relapse and resistance remain major challenges. Epigenetic alterations—particularly dysregulated DNA methylation and microRNA (miRNA) expression- are crucial in AML pathogenesis. Objective This study aimed to investigate the synergistic effects of azacitidine, a DNA methyltransferase inhibitor, and oleuropein, a natural polyphenol with anticancer properties, on AML cell lines (THP-1 and HL-60). Methods AML cells were treated with azacitidine, oleuropein, or their combination. Cell proliferation was evaluated using MTT assays, apoptosis was assessed via flow cytometry (Annexin V-FITC/PI staining), and miRNA expression levels were quantified using real-time PCR. Results Both azacitidine and oleuropein reduced cell viability and induced apoptosis in a dose- and time-dependent manner. The combination treatment significantly enhanced apoptosis, resulting in a 2.5-fold increase in Annexin V-positive HL-60 cells at 72 h. Additionally, the treatment modulated miRNA expression, upregulating miR-149-3p and miR-375, while downregulating miR-574-5p. Conclusion The synergistic effects of oleuropein and azacitidine suggest a promising therapeutic strategy for AML by targeting epigenetic mechanisms and miRNA pathways. Further in vivo studies and clinical trials are warranted to validate these findings and optimize treatment protocols.Keywords
All Related Versions
Funding Information
- Tabriz University of Medical Sciences (IR.TBZMED.VCR.REC.1399.183)
- Tabriz University of Medical Sciences (IR.TBZMED.VCR.REC.1399.183)
- Tabriz University of Medical Sciences (IR.TBZMED.VCR.REC.1399.183)
- Tabriz University of Medical Sciences (IR.TBZMED.VCR.REC.1399.183)
- Tabriz University of Medical Sciences (IR.TBZMED.VCR.REC.1399.183)
This publication has 23 references indexed in Scilit:
- Phytochemical profile and antiproliferative effect of Ficus crocata extracts on triple-negative breast cancer cellsBMC Complementary Medicine and Therapies, 2020
- miR-149-3p reverses CD8 + T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cellsOpen Biology, 2019
- Simultaneous downregulation of miR‐21 and miR‐155 through oleuropein for breast cancer prevention and therapyJournal of Cellular Biochemistry, 2018
- miR-149 promotes the myocardial differentiation of mouse bone marrow stem cells by targeting Dab2Molecular Medicine Reports, 2018
- A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemiaBMC Cancer, 2018
- Anticancer effects of oleuropeinBioFactors, 2017
- Ultraviolet irradiation increases green fluorescence of dihydrorhodamine (DHR) 123: false-positive results for reactive oxygen species generationPharmacology Research & Perspectives, 2017
- 5-aza-2′-deoxycytidine promotes migration of acute monocytic leukemia cells via activation of CCL2-CCR2-ERK signaling pathwayMolecular Medicine Reports, 2017
- Multivariate time series analysis on the dynamic relationship between Class B notifiable diseases and gross domestic product (GDP) in ChinaScientific Reports, 2016
- Oleuropein induces apoptosis via activation of caspases and suppression of phosphatidylinositol 3-kinase/protein kinase B pathway in HepG2 human hepatoma cell lineMolecular Medicine Reports, 2015